Asterion Cannabis Announces Election of New Director
Asterion is pleased to announce the voting results from the Company's 2020 annual general meeting of shareholders held on Friday,...
EyePoint Signs License Agreement to Develop Inflammation Treatment
EyePoint and Ocumension announced a license agreement for a post-operative inflammation treatment following ocular surgery in Asia.
Antares Announces 2020 Revenue Guidance Range of up to US$155 Million
Antares announced its 2020 net revenue guidance of US$135 to US$155 million, which includes potential revenue scenarios for AMAG’s Makena.
Naturally Splendid Terminates Agreements
Naturally Splendid Enterprises Ltd. (“Naturally Splendid”, “NSE” or “the Company”) (FRANKFURT:50N) (TSXV:NSP) (OTC:NSPDF) provides the following updates. The Company has...
Meridian Launches New High-Fidelity Polymerase
Meridian announced the launch of a High-Specificity Pfu HS Mix that provides high-fidelity amplification for CDx and clinical testing.
OncoSec Secures License to Select Clinical Trial Investigator Sites
OncoSec has purchased a multi-year Phesi ClinSite license to enable more precise planning for clinical trials of anticancer immunotherapies.
Cidara Therapeutics Announces Commencement of Rights Offering
Cidara Therapeutics commenced the previously announced rights offering to raise gross proceeds of approximately US$30 million.